Table 2.
Comments | Number of participants |
---|---|
Positive response |
|
Increased energy |
4/17 |
Reduced fatigue |
1/17 |
More alert |
1/17 |
Aided recovery from mild illness |
1/17 |
Reduced muscle soreness |
1/17 |
Initial improvement |
1/17 |
Minor change |
1/17 |
Negative response |
|
No change |
4/17 |
GIT symptoms (flatulence) |
1/17 |
Fatigue not improved | 1/17 |
Note: Thirteen participants provided a comment/s.